Tybourne Capital Management, a global, growth-oriented, fundamental equity investor in public and private markets, recently participated in SkyCell AG's USD 116m Series D financing round. SkyCell, a Swiss technology company active in the pharmaceutical supply chain, plans to use the investment for the continued expansion of its global footprint with a key focus on growth across the Americas, EMEA, and Asia.

VISCHER advised Tybourne Capital Management in the transaction. The team included Dr. Matthias Staehelin (Partner, Corporate/M&A) and Luzius Zumstein (Managing Associate, Corporate/M&A).

Author: Matthias Staehelin